Last deal

$1.27M
Local Amount - KRW 1.5B

Amount

Series A

Stage

30.09.2021

Date

2

all rounds

$1.65M

Total amount

date founded

Financing round

General

About Company
ZTI Biosciences is a South Korean company that develops nanomedicine therapeutics for cancer treatment.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2020

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

ZTI Biosciences offers cancer diagnosis and therapy solutions through the development of radio immunotherapeutic agents and sensitizers. Founded in 2020, the company is based in Daejeon, South Korea, and operates as a nano-carrier platform based on radiopharmaceuticals.
Contacts
Similar Companies
999
Iovance Biotherapeutics

Iovance Biotherapeutics

Iovance Biotherapeutics develops cancer immunotherapies based on tumor infiltrating lymphocytes (TIL).

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

New York, NY, USA

total rounds

8

total raised

$1.58B
Nanobiotix

Nanobiotix

Nanobiotix is a nanomedicine company developing cancer therapeutics.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Paris, France

total rounds

11

total raised

$358.46M
Nordic Nanovector

Nordic Nanovector

Nordic Nanovector is a biopharmaceutical company developing innovative targeted therapeutics for patients with haematological cancers.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Oslo, Norway

total rounds

4

total raised

$29.89M
Celsion

Celsion

Celsion is a biopharmaceutical company developing innovative cancer treatments.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Lawrenceville, Lawrence Township, NJ 08648, USA

total rounds

7

total raised

$113.79M

Financials

Funding Rounds
2
2

Number of Funding Rounds

$1.65M

Money Raised

Their latest funding was raised on 30.09.2021. Their latest investor Kiwoom Investment. Their latest round Series A

Date 
Funding Round 
Investors 
Money Raised 
Lead 
30.09.2021
4
$1.27M
Local Amount - KRW 1.5B
30.09.2020
2
$386.36K
Local Amount - KRW 450.02M
Spring Camp

Spring Camp

The leading representative office of defined VC in Seoul.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Seoul, South Korea

count Of Investments

241

count Of Exists

1

Low Partners Private Investment

Low Partners Private Investment is an investment firm.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

count Of Investments

7
Co-Investors
Investors
6
2

Number of lead investors

6

Number of investors

Investor 
Lead 
Round 
Partners 
Kiwoom Investment

Kiwoom Investment

The represented VC is a South Korean company that provides financial assistance to small businesses.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Location

Seoul, South Korea

count Of Investments

56
Korea Credit Guarantee Fund

Korea Credit Guarantee Fund

Korea Credit Guarantee Fund provides credit guarantees to small and medium-sized enterprises without tangible collateral.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Keywords

Financial Services, Finance, Credit

Location

Daegu, South Korea

count Of Investments

207

count Of Exists

1
TIGRIS investment

TIGRIS investment

Tigris Investment is a venture capital firm that invests in new technology companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Yeoksam-dong, Gangnam-gu, Seoul, South Korea

count Of Investments

10

Activity

Recent News
0